ReviewCNS drugs2012
Lisdexamfetamine dimesylate: a new therapeutic option for attention-deficit hyperactivity disorder.
Christopher Steer et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this papertrialcites it
ReviewCNS drugs2012
Christopher Steer et al.PubMed ↗Publisher ↗
No numbers read from the abstract.